Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julie Dardare
Observed names:
Dardare, Julie,
J. Dardare
Institutions:
Institut de Cancérologie de Lorraine,
Centre Hospitalier Régional et Universitaire de Nancy
Observed institutions:
Centre National de la Recherche Scientifique,
Institut de Cancérologie de Lorraine,
Centre Hospitalier Régional et Universitaire de Nancy,
CRAN,
Université de Lorraine
ORCID:
0000-0002-5315-1852
Observed ORCID:
0000-0002-5315-1852
OpenAlex ID:
A5024232075
SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
2020
·
Julie Dardare
, Andréa Witz
, et al.
·
International Journal of Molecular Sciences
·
110
PDF
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics
2025
·
Andréa Witz
, Julie Dardare
, et al.
·
Biomarker Research
·
57
PDF
Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities
2021
·
Julie Dardare
, Andréa Witz
, et al.
·
Pharmaceuticals
·
33
PDF
DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
2022
·
Julie Dardare
, Andréa Witz
, et al.
·
Frontiers in Oncology
·
20
PDF
ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
2023
·
Margaux Betz
, Vincent Massard
, et al.
·
Cancers
·
19
PDF
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
2023
·
Andréa Witz
, Julie Dardare
, et al.
·
Scientific Reports
·
18
PDF
Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
2024
·
Andréa Witz
, Julie Dardare
, et al.
·
Clinical and Experimental Medicine
·
16
PDF
DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib
2024
·
Julie Dardare
, Andréa Witz
, et al.
·
Cell Death Discovery
·
8
PDF
Radiotherapy in the management of PDAC, from past to present
2025
·
Julie Dardare
, Nicolas Martz
, et al.
·
Translational Oncology
·
4
Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers
2023
·
Pauline Gilson
, Celso Pouget
, et al.
·
Scientific Reports
·
4
PDF
A Novel Droplet Digital PCR Assay for BRCA1 and RAD51C Methylation
2025
·
Cassandra Michel
, Alizée Simon
, et al.
·
Journal of Molecular Diagnostics
·
3
Decoding mutational signatures in breast cancer: Insights from a multi-cohort study
2025
·
Margaux Betz
, Andréa Witz
, et al.
·
Translational Oncology
·
3
776P Liquid biopsy for the determination of homologous recombination deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study
2024
·
A. Harlé
, M. Husson
, et al.
·
Annals of Oncology
·
3
PDF
REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer?
2024
·
Julie Dardare
, Andréa Witz
, et al.
·
Translational Lung Cancer Research
·
3
Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies
2025
·
Julie Dardare
, Nicolas Martz
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
PDF
Place de l’ADN tumoral circulant dans la prise en charge des cancers : entre défis et nouvelles perspectives
2022
·
Paul Toussaint
, Julie Dardare
, et al.
·
Innovations & Thérapeutiques en Oncologie
·
2
35P Increased sensitivity to olaparib by BRCA1/2 knockdown using a CRISPR/Cas9-mediated knock-in method in pancreatic cancer cell lines
2021
·
A. Witz
, J. Dardare
, et al.
·
Annals of Oncology
·
1
PDF
40P Genomic concordance between small extracellular vesicle-derived DNA and parental tumor cells revealed by whole-genome sequencing
2026
·
B. David
, A. Witz
, et al.
·
ESMO Open
PDF
Abstract PS2-09-14: When interception needs a second chance: ctDNA dynamics in ER+/HER2- advanced breast cancer treated with 1st line CDK4/6 inhibitors - Insights from the CICLADES study
2026
·
V. Massard
, M. Betz
, et al.
·
Clinical Cancer Research
Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of IDH Variants in Solid Tumors and Hematological Malignancies
2026
·
Pauline Gilson
, Marc Muller
, et al.
·
International Journal of Molecular Sciences
PDF
Les biomarqueurs théranostiques des inhibiteurs de PARP : recommandations et enjeux organisationnels pour les laboratoires français
2025
·
Gilson, Pauline
, Witz, Andréa
, et al.
·
HAL
Investigating survival in patients undergoing surgery for pancreatic ductal adenocarcinoma using liquid biopsy: Preliminary results of PAN-CGE-BLISS pilot study.
2025
·
Alexandre Harle
, Julie Dardare
, et al.
·
Journal of Clinical Oncology
PDF
13P Methylation of BRCA1 and RAD51C promoters determined by droplet digital PCR predicts homologous repair deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study in paired FFPE and plasma samples and the ICL ovarian cohort
2024
·
C. Michel
, A. Witz
, et al.
·
ESMO Open
PDF
Rôles de la protéine Damaged DNA Binding 2 dans la progression tumorale et dans la réponse aux traitements dans l’adénocarcinome canalaire pancréatique
2023
·
Julie Dardare
·
theses.fr (ABES)
160P CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
2023
·
M. Betz
, M. Husson
, et al.
·
ESMO Open
PDF
Show more works
View as search
Works count:
27
Citation count:
306
H-index:
8
I10-index:
7
Year
Topic
Type